Background: Among rheumatic disease-related lung disease, interstitial lung disease (ILD) is the most prevalent and contributing to the mortality and morbidity. Increasing number of recent reports dealing with ILD of rheumatoid arthritis (RA), Sjögren's syndrome (pSS) and systemic sclerosis (SSc), multidisciplinary discussions (MDDs) have been growing interest for diagnostic accuracy with dedicated service. There was little evidence indicating that multidisciplinary outpatient clinic resulted in improvements in clinical outcomes including satisfaction and belief. Objectives: We have designed validated a scale of evaluating coping strategies about satisfaction and belief in patient of ILD and rheumatic disease with multidisciplinary approach. Methods: From December 2015 to September 2016, we evaluated 20 patients of rheumatoid disease with ILD and 20 patients of idiopathic pulmonary fibrosis. Patient perceptions of illness, treatment beliefs, and moods were measured via the multiple choice questionnaires presenting brief Illness perception questionnaire, beliefs about medicines questionnaire, and patient health questionnaire 2 for comparing the effectiveness of MDDs and routine ILD management. Results: In univariate analysis, beliefs in necessity and concerns of medication differed significantly high in multidisciplinary outpatient clinic for people with ILD (intentional or unintentional). When controlling for other factors that may impact medication nonadherence, more belief in necessity of medication and greater positive emotional response to disease were presented in multidisciplinary outpatient clinic for people with ILD (OR 1.51, CI 1.01-1.82). Conclusions: The MDD including rheumatologist and pulmonologist allows a satisfactory management comparing routine ILD management. It showed better coping improvements about the emotional distress, pain, and beliefs about treatment. Further research to investigate long-term clinical outcomes of multidisciplinary outpatient clinic for people with ILD is required, overlying the enhancement of mutual communication. References: [1] Vliet Vlieland TP. Multidisciplinary team care and outcomes in rheumatoid arthritis.
Background Behcet’s disease (BD) has a high incidence in countries of the middle through to the far East and there are studies of demographics and disease characteristics from Turkey and Greece, through to Japan1. No such information exists for Cyprus. One would expect a high incidence, but this has never been studied. There are regional differences in disease characteristics and this would be important to know regarding Cyprus, given its geographical position in an area of high prevalence of BD. Objectives This is the first attempt at describing the patient characteristics (demographics, symptomatic presentation/organ involvement and treatment) of Behcet’s Disease in Cyprus. Methods Cypriot rheumatologists were invited to record the relevant information on a set pro forma for each of their patients with BD fullfilling the Behcet’s Disease international classification criteria. Results 50 patients were detected in this first effort. The Male to Female ratio of 1.13 to 1 was similar to Turkey and Greece. Peak incidence was equal in the 3rd and 4th decades and mean age of diagnosis was 31 years. All but two patients were Greek Cypriot. There was a very low association with other family members with ABD, or recurrent oral apthae. HLA B51 status was untested in 15/50 patients and 69% of those tested were positive. Of all the symptoms recorded, the main ones characteristic of the Cypriot population were present in the following pattern: Oral ulcers occurred in 100% of the patients. Genital ulcers and arthrits in 56% and uveitis in 52%. Superficial thrombophlebitis occurred in 8%. 2% had DVT and 2% had aneurysms. (table) Conclusions This was the first attempt at characterizing BD and studying its prevalence in Cyprus. The number of patients is small and conclusions have to be treated with caution. However, finding 50 patients amongst a population of around a million, already puts the prevalence of BD in Cyprus at 10 times that of the UK for example. This is still the beginning, and a concerted national effort must be undertaken with intensive case finding in order to detect undiagnosed cases, and eventually come up with basic epidemiological data to add to the global picture of the disease. References Zouboulis, CC. Epidemiology of Adamantiades-Behcet’sDisease. Annalesde Medicine Interne. 1999;150(6):488-98 Disclosure of Interest None Declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.